Detalles de la búsqueda
1.
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation.
Ann Hematol
; 102(7): 1915-1925, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37079070
2.
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.
Support Care Cancer
; 31(6): 350, 2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37227523
3.
Do CAR-T and Allogeneic Stem Cell Transplant Both Have a Place in Lymphoid Neoplasms?
Int J Mol Sci
; 24(2)2023 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674573
4.
Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience.
Support Care Cancer
; 30(1): 585-591, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34347181
5.
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon.
Int J Mol Sci
; 23(21)2022 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36362130
6.
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant.
Ann Hematol
; 99(2): 331-341, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31853703
7.
Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety.
Transfus Apher Sci
; 59(6): 102911, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32859502
8.
Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34+ Cell and Platelet Counts.
Biol Blood Marrow Transplant
; 25(8): 1586-1591, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31002994
9.
A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model.
Biol Blood Marrow Transplant
; 24(3): 608-613, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29032271
10.
Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after highdose melphalan and autologous stem cell transplantation.
Ann Hematol
; 102(8): 2297-2298, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37347271
11.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica
; 102(11): 1931-1935, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28775121
12.
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
Ann Hematol
; 93(8): 1413-20, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24647684
13.
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.
Br J Haematol
; 183(5): 819-822, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29193017
14.
Very long-lasting remission of refractory T-large granular lymphocytes leukemia and myeloma by lenalidomide treatment.
Eur J Haematol
; 91(2): 183-6, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23692265
15.
Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.
Expert Opin Biol Ther
; 22(3): 407-421, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463175
16.
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
Cancers (Basel)
; 13(11)2021 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34072068
17.
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials.
Expert Rev Hematol
; 12(8): 665-684, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31251688
18.
Effectiveness of CAR-T treatment toward the potential risk of second malignancies.
Front Immunol
; 15: 1384002, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38756776
19.
Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?
Am J Hematol
; 86(11): 957, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21990093
20.
Long-lasting remission of a relapsed large cell non-Hodgkin's lymphoma by Y90 ibritumomab tiuxetan as salvage therapy.
Tumori
; 95(1): 129-30, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19366073